INOTIV INC (NOTV) Stock Price, Forecast & Analysis

NASDAQ:NOTV • US45783Q1004

0.2848 USD
-0.01 (-1.86%)
At close: Feb 13, 2026
0.29 USD
+0.01 (+1.83%)
After Hours: 2/13/2026, 8:00:01 PM

NOTV Key Statistics, Chart & Performance

Key Statistics
Market Cap9.80M
Revenue(TTM)513.02M
Net Income(TTM)-68.63M
Shares34.40M
Float31.06M
52 Week High4.51
52 Week Low0.28
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-2.03
PEN/A
Fwd PEN/A
Earnings (Next)05-05
IPO1997-11-25
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
NOTV short term performance overview.The bars show the price performance of NOTV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

NOTV long term performance overview.The bars show the price performance of NOTV in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of NOTV is 0.2848 USD. In the past month the price decreased by -49.81%. In the past year, price decreased by -92.47%.

INOTIV INC / NOTV Daily stock chart

NOTV Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
NOTV Full Technical Analysis Report

NOTV Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NOTV. NOTV has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NOTV Full Fundamental Analysis Report

NOTV Financial Highlights

Over the last trailing twelve months NOTV reported a non-GAAP Earnings per Share(EPS) of -2.03. The EPS increased by 55.97% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -8.9%
ROE -50.45%
Debt/Equity 0.04
Chartmill High Growth Momentum
EPS Q2Q%18.63%
Sales Q2Q%0.84%
EPS 1Y (TTM)55.97%
Revenue 1Y (TTM)4.54%
NOTV financials

NOTV Forecast & Estimates

8 analysts have analysed NOTV and the average price target is 4.93 USD. This implies a price increase of 1631.03% is expected in the next year compared to the current price of 0.2848.

For the next year, analysts expect an EPS growth of 8.11% and a revenue growth 4.92% for NOTV


Analysts
Analysts82.5
Price Target4.93 (1631.04%)
EPS Next Y8.11%
Revenue Next Year4.92%
NOTV Analyst EstimatesNOTV Analyst Ratings

NOTV Ownership

Ownership
Inst Owners23.91%
Ins Owners9.63%
Short Float %6.63%
Short Ratio4.36
NOTV Ownership

NOTV Latest News, Press Relases and Analysis

All NOTV news

NOTV Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
TMO THERMO FISHER SCIENTIFIC INC20.34191.544B
DHR DANAHER CORP25.03151.823B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28133.2444.524B
A AGILENT TECHNOLOGIES INC20.7835.404B
IQV IQVIA HOLDINGS INC12.7628.637B
MTD METTLER-TOLEDO INTERNATIONAL29.4427.606B
WAT WATERS CORP22.3519.04B
WST WEST PHARMACEUTICAL SERVICES31.9117.525B
ILMN ILLUMINA INC22.5617.486B
MEDP MEDPACE HOLDINGS INC25.4611.72B

About NOTV

Company Profile

NOTV logo image Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,945 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Company Info

INOTIV INC

2701 Kent Ave

West Lafayette INDIANA 47906 US

CEO: Robert W. Leasure Jr.

Employees: 1945

NOTV Company Website

NOTV Investor Relations

Phone: 13174634527

INOTIV INC / NOTV FAQ

Can you describe the business of INOTIV INC?

Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,945 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.


What is the current price of NOTV stock?

The current stock price of NOTV is 0.2848 USD. The price decreased by -1.86% in the last trading session.


Does NOTV stock pay dividends?

NOTV does not pay a dividend.


How is the ChartMill rating for INOTIV INC?

NOTV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Is INOTIV INC (NOTV) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NOTV.


Who owns INOTIV INC?

You can find the ownership structure of INOTIV INC (NOTV) on the Ownership tab.


What is the outstanding short interest for INOTIV INC?

The outstanding short interest for INOTIV INC (NOTV) is 6.63% of its float.